Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

BCLI

Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics is a biotech company based in New York with a mission to revolutionize the treatment of neurodegenerative diseases. Using its proprietary cell therapy platform, NurOwn,...

Brainstorm Cell Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

JAGX

Jaguar Health

San Francisco-based pharmaceuticals company, Jaguar Health, Inc., has established itself as a major player in the treatment of gastrointestinal distress, with a particular focus on chronic and debi...

Jaguar Health Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

TRX

Tissue Regenix Group

TRX Gold Corporation, a Canadian company, is delving into the exploration, development, and production of mineral property interests in the United Republic of Tanzania. Its main focus is on discove...

Tissue Regenix Group Annual Report 2023

Healthcare Biotechnology LSE 51-200

SAGE

Sage Therapeutics

Sage Therapeutics, Inc., a biopharmaceutical company headquartered in Cambridge, Massachusetts, has announced the development and commercialization of brain health medicines. Specifically, the comp...

Sage Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

SGEN

Seagen

Seattle-based biotechnology company Seagen Inc. is taking the world of cancer treatment by storm with their innovative new therapies. Approaching cancer treatment from all angles, Seagen offers ADC...

Seagen Annual Report 2021

Healthcare Biotechnology NASDAQ 501-1000

KMPH

KemPharm Inc

KemPharm is a clinical-stage pharmaceutical company that uses its innovative LAT platform technology to discover and develop prodrugs, with the goal of treating serious medical conditions. Its drug...

KemPharm Inc Annual Report 2020

Healthcare Biotechnology NASDAQ 11-50

VTAE

Vitae

Vitae, a company dedicated to supporting the professional development of researchers, has emerged as a global leader in its field. With its focus on helping institutions achieve research excellence...

Vitae Annual Report 2019

Healthcare Biotechnology NASDAQ 11-50

MREO

Mereo BioPharma Group plc

Mereo BioPharma Group plc, a UK-based biopharmaceutical firm, is expanding its portfolio of products aimed at treating oncology and rare diseases. The company's lead product candidate, etigilimab (...

Mereo BioPharma Group plc Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CARA

Cara Therapeutics

Cara Therapeutics, a biopharmaceutical company focused on treating pruritus, has made significant strides in the development and commercialization of its therapeutics. The company's flagship produc...

Cara Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

AOR

AorTech International plc

AorTech International Plc is a UK-based company that is dedicated to bringing its innovative biomedical polymer technology to the commercial market. As a publicly traded company on the UK London St...

AorTech International plc Annual Report 2018

Healthcare Biotechnology LSE 1-10

ANPC

AnPac Bio-Medical Science Co., Ltd.

In the rapidly evolving world of biotechnology, AnPac Bio-Medical Science Co., Ltd. has emerged as a company that is making significant strides in its field. Based in Lishui in the People's Republi...

AnPac Bio-Medical Science Co., Ltd. Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200

HSKA

Heska

Heska Corporation, a leading manufacturer and vendor of diagnostic and specialty products and solutions for veterinary practitioners, has a global presence in the United States, Canada, Mexico, Ger...

Heska Annual Report 2021

Healthcare Biotechnology NASDAQ 201-500

CLBS

Caladrus Biosciences

Caladrius Biosciences Inc., a prominent American biopharmaceutical company, has been making waves in the cell therapy industry due to its subsidiary PCT's expertise in development and manufacturing...

Caladrus Biosciences Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200

IXC

Invex Therapeutics Ltd

Invex Therapeutics is a biopharmaceutical company that specializes in repurposing an existing drug, Exenatide, for the treatment of neurological conditions caused by, or related to, raised intracra...

Invex Therapeutics Ltd Annual Report 2023

Healthcare Biotechnology ASX 1-10

GTHX

G1 Therapeutics

G1 Therapeutics, Inc. is making waves in the world of commercial-stage biopharmaceutical companies, focusing on the discovery, development, and commercialization of small molecule therapeutics for ...

G1 Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200